Research on antihyperglycemic drug therapies in patients with type 2 diabetes mellitus in Japan (II): The effectiveness on glycemic control (JDDM7)

Journal of the Japan Diabetes Society

Volumn 49, Issue 12, 2006, Pages 919-927

  Kanatsuka, Azuma ^a   Kawai, Koichi ^b   Hirao, Koichi ^c   Oishi, Mariko ^d   Takagi, Hirofumi ^e   Kobayashi, Masashi ^f  

^a Chiba Central Medical Center   (Japan)

^b Kawai Clinic   (Japan)

^c HEC Science Clinic   (Japan)

^d Oishi Clinic   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846781787     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ohkubo Y, Kishikata H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract 28 : 103-117
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 : 837-853
3. Japanese source
4. Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M, Takagi H, Kawai K, and Japan Diabetes Clinical Data Management Study Group (2006) The status of diabetes control and antidiabetic drug therapy in Japan : a cross sectional survey of 17,000 patients with diabetes mellitus (JDDM1). Diabetes Res Clin Pract 73 : 198-204
5. Saydah SH, Fradkin J, Cowie C (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 : 335-342
6. Chuang ML, Tsai ST, Huang BY, Tai TY on the Dibcare-Asia 1998 Study Group (2002) The status of diabetes control in Asia : a cross sectional survey of 24,317 patients with diabetes mellitus in 1998. Diabet Med 19 : 978-985
7. Japanese source
8. Japanese source
9. Japanese source
10. Japanese source
11. Japanese source
12. Japanese source
13. Herman LS, Schersten B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A (1994) Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations : a double-blind controlled study. Diabetes Care 17 : 1100-1109
14. Shank M, Del Prato S, Defronzo RA (1995) Bed-time insulin/daytime glipizide effective therapy for sulfonylurea failures in NIDDM. Diabetes 44 : 165-172
15. Guigliano D, Quatraro A, Consoli G, Minei A, Celliero A, De Rosa N, D'Onofrio F (1993) Metformin for obese, insulin-treated diabetic patients : improvement in glycemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 44 : 107-112
16. Kanatsuka A, Kobayashi M (2004) The relation between the phenotypes and the efficacy of drug (s) in type 2 diabetic patients : CoDiC-based analyses on the clinical data obtained at multiple institutions. Diabetologia 47 : Supplement 1, A358
17. Lindholm A, McEwen J, Riis AP (1999) Improved postprandial glycemic control with insulin aspart. Diabetes Care 22 : 801-805
18. Ciszak E, Beals JM, Frank BH, Baker JC, Carter ND, Smith GD (1995) Role of C-terminal β-chain residues in insulin assembly : the structure of hexameric LysB28 ProB29 human insulin. Structure 3 : 615-622